Testosterone Replacement 2015. Jonathan Insel,MD,FACE

Similar documents
Testosterone in Old(er) Men

Testosterone Replacement Therapy. Craig Ensign, MPAS, PA-C University of Utah School of Medicine Urology Division

Hypogonadism and Testosterone Replacement in Men with HIV

Testosterone; What s all the hype? KRISTEN WYRICK, LTCOL,USAFR, MC USUHS, FAMILY MEDICINE JOINT BASE LANGLEY-EUSTIS

Continuity Clinic Educational Didactic. December 8 th December 12 th

Testosterone Treatment: Myths Vs Reality. Fadi Al-Khayer, M.D, F.A.C.E

Testosterone: Is Just for the GOP?

GUIDELINES ON MALE HYPOGONADISM

CONCORD INTERNAL MEDICINE TESTOSTERONE DEFICIENCY PROTOCOL

Testosterone, Growth Hormone and Bioidentical Hormones Prescription Issues

Testosterone Treatment in Older Men

X-Plain Low Testosterone Reference Summary

Prevalence Diagnosis and Treatment of Hypogonadism in Primary Care Practice by Culley C. Carson III, MD, Boston University Medical Campus

CONSIDERATIONS BEFORE TESTOSTERONE THERAPY WHAT S UP WITH THE T?

BIOCHEMICAL TESTS FOR THE INVESTIGATION OF COMMON ENDOCRINE PROBLEMS IN THE MALE

Male New Patient Package

The ABC s and T s of Male Infertility

Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline

Definitions. Androgen deficiency. Clinical Hypogonadism* Low serum testosterone level Also called biochemical hypogonadism

Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes:

Medication Policy Manual. Date of Origin: April 13, Topic: Testosterone cypionate, testosterone enanthate

Us TOO University Presents: Understanding Diagnostic Testing

SRO Tutorial: Prostate Cancer Treatment Options

testosterone_pellet_implantation_for_androgen_deficiency_in_men 10/2015 N/A 11/ /2015 This policy is not effective until December 30, 2015

Focus. Andropause: fact or fiction? Introduction. Johan Wilson is an Auckland GP KEY POINTS

PROSTATE CANCER. Normal-risk men: No family history of prostate cancer No history of prior screening Not African-American

HEALTH NEWS PROSTATE CANCER THE PROSTATE

Male Patient Questionnaire & History

An Introduction to PROSTATE CANCER

Testosterone Testing

Testosterone. Testosterone For Women

Shalender Bhasin, MD. Glenn R Cunningham, MD. Mohit Khera, MD, MBA, MPH

Treatment of Males with Low Testosterone

Childhood. Unknown. Minimal gonadotrophin stimulation. Signal that dampens GNRH stimulation? Signal that dampens GNRH stimulation?

TESTOSTERONE The Future?

Thomas A. Kollmorgen, M.D. Oregon Urology Institute

WHAT TO EXPECT FROM YOUR TREATMENT

PSA Screening for Prostate Cancer Information for Care Providers

Male Patient Questionnaire & History

MMM. Topic Diagnosis and Testosterone Replacement Therapy for Androgen Deficiency in the Aging Male (ADAM)

Beyond the PSA: Genomic Testing in Localized Prostate Cancer

Dealing with Erectile Dysfunction During and After Prostate Cancer Treatment For You and Your Partner

TO SCREEN OR NOT TO SCREEN: THE PROSTATE CANCER

Testosterone for women, who when and how much?

Hormone Restoration: Is It Right for You? Patricia A. Stafford, M.D. Founder, Wellness ReSolutions

Male New Patient Package

Testosterone Therapy in the 21st Century Man.! Wayne Kuang MD MD for Men LLC 505 Urology LLC

Talk to your doctor about low testosterone

PSA screening in asymptomatic men the debate continues keyword: psa

Male Hypogonadism. Hypogonadism is characterised by impaired testicular function, which may affect spermatogenesis and/or testosterone synthesis.

Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D.

to Know About Your Partner s

EPILEPSY. & Men s Health

PROSTATE CANCER. Get the facts, know your options. Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.

1. What is the prostate-specific antigen (PSA) test?

ANDROGEN DEFICIENCY A GUIDE TO MALE HORMONES A BOOKLET IN THE SERIES OF CONSUMER GUIDES ON MALE REPRODUCTIVE HEALTH FROM

TUE Applications for Testosterone Physician Worksheet

Prostate Cancer Screening: Are We There Yet? March 2010 Andrew M.D. Wolf, MD University of Virginia School of Medicine

Testosterone deficiency: myth, facts, and controversy Martin Miner, MD, 1 Jack Barkin, MD, 2 Matt T. Rosenberg, MD 3 1

Analysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data

Age Management Panel Male Fasting Panel

Pituitary disease for GPs. Dr Tricia Tan Metabolic Medicine and Endocrinology

Sex Hormone Testing by Mass Spectrometry

Historical Basis for Concern

Early Prostate Cancer: Questions and Answers. Key Points

UPMC Rehab Grand Rounds

PROSTATE CANCER 101 WHAT IS PROSTATE CANCER?

Prostate Cancer Action Plan: Choosing the treatment that s right for you

ANDROPAUSE. Male Menopause

Anatomy: The sella is a depression in the sphenoid bone that makes up part of the skull base located behind the eye sockets.

The Truth about Testosterone Therapy

Understanding the long-term risks and benefits of testosterone replacement

Update on Surgical Treatment of Pituitary Tumors. Kristen Riley, MD, FACS Associate Professor, Division of Neurosurgery, Department of Surgery

Ordering and interpreting thyroid tests in children. Paul Kaplowitz, MD, PhD Children s National Medical Center, Washington, DC

What You Need to Know for Better Bone Health

More information >>> HERE <<<

A Woman s Guide to Prostate Cancer Treatment

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014

Understanding the. Controversies of. testosterone replacement. therapy in hypogonadal men with prostate cancer. controversies surrounding

Chapter 45: Hormones and the Endocrine System

NDA LABELING SUPPLEMENT AND PMR REQUIRED REMS MODIFICATION NOTIFICATION

Prostate Cancer. There is no known association with an enlarged prostate or benign prostatic hyperplasia (BPH).

Transcription:

Testosterone Replacement 2015 Jonathan Insel,MD,FACE

Sometimes life has a way of neutering us.

NN 74 YO RETIRED SURGEON c/o BREAST SWELLING 30s MUMPS ORCHITIS ; UNABLE TO FATHER KIDS ETOH : 6 COCKTAILS A DAY DON T MIND BEING AN OLD MAN, BUT DAMN IF I WANT TO TURN INTO AN OLD WOMAN

FINDINGS GYNECOMASTIA (3-4cm.) SMALL TESTES TESTOSTERONE 342 (300-1200) LH 57.5 (6-30) LFTS: Nl.

REST OF THE STORY RX.: DEPOTESTOSTERONE 100-200mg./mos. GYNECOMASTIA MELTED AWAY INCREASED POTENCY AND PEP WIFE ACCOMPANIED PATIENT TO OFFICE: IT S LIKE A MIRACLE

Normal Physiology

Causes of Primary Hypogonadism Kleinfelter s (47 XXY) Infection-Mumps orchitis Vanishing testis Trauma Radiation

Testes:the most accessible endocrine gland Primary Hypogonadism: Normal

Causes of Secondary Hypogonadism Pituitary tumors Empty sella Opiates Kallman s syndrome Hemochromatosis HIV

Causes of Mixed Primary and Secondary Hypogonadism Aging Obesity/ Type 2 DM Renal failure Steroids COPD Cirrhosis

WEIGHT LOSS l

Making the Diagnosis AM (prior 10 AM) Fasting Testosterone <300 ng/dl x2 Free Testosterone <50 pg/ml LH,FSH ( before initiation of testosterone Rx) Prolactin MRI Pituitary if 2 nd hypogonadism: severe 2 nd Hypogonadism (T<150) elevated prolactin panhypopituitarism mass effect: visual field loss, headaches 3 rd /6 th nerve palsy

Why Free Testosterone? SHBG Aging SHBG Obesity Cirrhosis HyperT4

A 52 yo obese male complains of erectile dysfunction. Normal libido. AM testosterone: 267 (300-750) The next step would be to : 1. Calculate or measure a free testosterone. 2. Refer to a medical weight loss program. 3. Stratify coronary risk. 4. Provide a sample of Cialis,Levitra, or Viagra. 5. Consider all of the above.

64 YO RETIRED INTERNIST ERECTILE DYSFUNCTION RECENTLY REMARRIED ( I FIND HER VERY EXCITING ) BUT UNABLE TO CONSUMMATE MARRIAGE TRIAL ANDROGENS AND PSYCHOTHERAPY FAILED

Making the diagnosis

FINDINGS SLIGHT GYNECOMASTIA NL. TESTICULAR VOLUME NL.CARDIOVASCULAR AND NEURO. EXAM LAB: TESTOSTERONE 530

THE REST OF THE STORY LAB : PROLACTIN 332 CT : PITUITARY MACROADENOMA RX.: BROMOCRIPTINE 2.5mg.bid 2 wks. later his young wife accompanied patient to office visit: HE HAS BECOME A STUD PROLACTIN : 3.9

Free Testosterone LH/FSH Diagnosis Primary Hypogonadism Nl. Compensated Primary Secondary Hypogonadism Low Nl. Combined hypogonadism

T Testosterone undecanoate injections q 6 weeks

37 yo male c/o fatigue Testosterone 275 Placed on Testosterone Inquires about fertility

Testosterone Rx. : Male contraceptive-reduces spermatogenesis If man with secondary hypogonadism desires fertility : Mild 2 nd hypogonadism-clomiphene, 50 mg 3 times a week. (augments LH/FSH ) Severe 2 nd hypogonadism-hcg : 1000-2000 units SQ/IM 3 times a week

Patients for whom testosterone contraindicated Very High risk: Metastatic prostate cancer Breast cancer Moderate to high risk: Unevaluated prostatic nodule PSA >4 (>3 for men at high risk for prostate cancer) HCT>50 Severe urinary outlet obstructive symtoms Uncontrolled CHF Potential risk: Clotting disorders-thrombophilia (Factor 5 Leidin) Elderly

Benefits of Testosterone replacement in the elderly Reduces frailty Improves energy,libido,bone density? Reduces cardiovascular events

Risks in the elderly? Increases cardiovascular events Unmask prostate cancer (50% men 70-80 have histological prostate cancer) Aggravate urinary outlet obstruction Polycythemia? Increase DVT risk ONLY TREAT IF CLEARLY HYPOGONADAL

Testosterone -? Cardiovascular Risk Retrospective studies: conflicting data? Increase risk in individuals who have preexisting CAD In one small prospective study (Tom trial) events occurred in the first few months of exposure and more frequent at higher Testosterone levels

Testosterone Rx.: Prostate Ca Stress Test BASELINE AND F/U PSA BASELINE AND F/U DRE Increase PSA > 1.4 ng PSA > 4 ng PSA velocity >.4 ng/year over 2 years

Adverse Events and Testosterone Levels 300-400 T X Do not overtreat older men

Testosterone should be prescribed only after the diagnosis and cause of hypogonadism has been clearly established and with proper surveillance after testosterone initiated.